Healix

Outpatient Parenteral Antimicrobial Therapy (OPAT) for Treatment of Complicated Intra-Abdominal Infections

Authors:
Fernando S. Alvarado,MD – Infectious Disease Consultants, Altamonte Springs, FL
Ramesh V. Nathan, MD – Mazur, Statner, Dutta, Nathan, PC, Thousand Oaks, CA
H. Barry Baker, MD, FACP – Infectious Disease Physicians, PA, Miami, FL
Richard L. Levine, MD – Infectious Disease Physicians, PA, Miami, FL
Andrew H. Krinsky, MD – Infectious Diseases Associates, Sarasota, FL
Richard C. Prokesch, MD – Infectious Disease Associates, Riverdale, GA
Philip Brachman, MD – Atlanta ID Group, PC, Atlanta, GA
Lucinda J. Van Anglen, PharmD – Healix Infusion Therapy, Inc., Sugar Land, TX

View Poster View Abstract

View All

Phase II and Phase III Studies

Healix regularly and actively supports Phase II and Phase III clinical trials in each of our specialty areas, including active studies in therapies for COVID-19, Multiple Sclerosis and Intestinal Bowel Disease.

For information on partnering with Healix on a study, please contact us.

FacebookTwitterLinkedInarrow1arcsearchiconowdtnotfound